KR100194307B1 - 약학적화합물 - Google Patents

약학적화합물 Download PDF

Info

Publication number
KR100194307B1
KR100194307B1 KR1019920007116A KR920007116A KR100194307B1 KR 100194307 B1 KR100194307 B1 KR 100194307B1 KR 1019920007116 A KR1019920007116 A KR 1019920007116A KR 920007116 A KR920007116 A KR 920007116A KR 100194307 B1 KR100194307 B1 KR 100194307B1
Authority
KR
South Korea
Prior art keywords
dirithromycin
solvate
dilitthromycin
water
acetone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019920007116A
Other languages
English (en)
Korean (ko)
Other versions
KR920019364A (ko
Inventor
마이클 그린 제임스
마리 핸킨스 홀리
알란 스테펜슨 그레고리
데일 위쓰 데이비드
Original Assignee
피터 지. 스트링거
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 지. 스트링거, 일라이 릴리 앤드 캄파니 filed Critical 피터 지. 스트링거
Publication of KR920019364A publication Critical patent/KR920019364A/ko
Application granted granted Critical
Publication of KR100194307B1 publication Critical patent/KR100194307B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
KR1019920007116A 1991-04-29 1992-04-27 약학적화합물 Expired - Fee Related KR100194307B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29
US07/692,842 1991-04-29
US7/692,842 1991-04-29

Publications (2)

Publication Number Publication Date
KR920019364A KR920019364A (ko) 1992-11-19
KR100194307B1 true KR100194307B1 (ko) 1999-06-15

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019920007116A Expired - Fee Related KR100194307B1 (ko) 1991-04-29 1992-04-27 약학적화합물
KR1019920007117A Expired - Fee Related KR100193742B1 (ko) 1991-04-29 1992-04-27 디리트로마이신을 함유하는 약학 제형

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019920007117A Expired - Fee Related KR100193742B1 (ko) 1991-04-29 1992-04-27 디리트로마이신을 함유하는 약학 제형

Country Status (27)

Country Link
EP (2) EP0511800B1 (cg-RX-API-DMAC7.html)
JP (2) JP3135672B2 (cg-RX-API-DMAC7.html)
KR (2) KR100194307B1 (cg-RX-API-DMAC7.html)
CN (2) CN1069197C (cg-RX-API-DMAC7.html)
AT (2) ATE144425T1 (cg-RX-API-DMAC7.html)
AU (2) AU655978B2 (cg-RX-API-DMAC7.html)
BR (2) BR9201540A (cg-RX-API-DMAC7.html)
CA (2) CA2067275C (cg-RX-API-DMAC7.html)
CY (2) CY1946A (cg-RX-API-DMAC7.html)
CZ (2) CZ282218B6 (cg-RX-API-DMAC7.html)
DE (2) DE69211220T2 (cg-RX-API-DMAC7.html)
DK (2) DK0511799T3 (cg-RX-API-DMAC7.html)
ES (2) ES2088098T3 (cg-RX-API-DMAC7.html)
FI (2) FI921876A7 (cg-RX-API-DMAC7.html)
GR (2) GR3020439T3 (cg-RX-API-DMAC7.html)
HK (2) HK153696A (cg-RX-API-DMAC7.html)
HU (2) HU213613B (cg-RX-API-DMAC7.html)
IE (2) IE76296B1 (cg-RX-API-DMAC7.html)
IL (2) IL101705A (cg-RX-API-DMAC7.html)
MX (2) MX9201946A (cg-RX-API-DMAC7.html)
MY (2) MY109498A (cg-RX-API-DMAC7.html)
NO (2) NO179504C (cg-RX-API-DMAC7.html)
NZ (2) NZ242506A (cg-RX-API-DMAC7.html)
RU (2) RU2070203C1 (cg-RX-API-DMAC7.html)
TW (2) TW216399B (cg-RX-API-DMAC7.html)
YU (2) YU44392A (cg-RX-API-DMAC7.html)
ZA (2) ZA922776B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (cg-RX-API-DMAC7.html) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
PT915899E (pt) * 1996-07-29 2004-11-30 Abbott Lab Preparacao da forma cristalina ii da eritromicina
JP2001501207A (ja) * 1996-09-24 2001-01-30 イーライ・リリー・アンド・カンパニー コーティングされた粒子製剤
RU2147234C1 (ru) * 1999-03-09 2000-04-10 Жемчугов Владислав Евгеньевич Препарат для профилактики и лечения особо опасных инфекционных заболеваний
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
RU2212242C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Антибиотик сумазид
MX2009005977A (es) * 2006-12-05 2009-06-17 Pfizer Polimorfos de motilida.
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FI921876A0 (fi) 1992-04-27
FI921877A0 (fi) 1992-04-27
EP0511800B1 (en) 1996-10-23
MX9201944A (es) 1992-11-01
CN1069197C (zh) 2001-08-08
IL101705A (en) 1996-01-31
AU1525792A (en) 1992-11-05
DE69211220T2 (de) 1996-11-07
ZA922776B (en) 1993-10-15
KR920019364A (ko) 1992-11-19
CA2067275C (en) 2002-11-26
BR9201540A (pt) 1992-12-01
DE69211220D1 (de) 1996-07-11
ES2088098T3 (es) 1996-08-01
YU44492A (sh) 1994-06-24
MY114226A (en) 2002-09-30
HK153696A (en) 1996-08-16
RU2070203C1 (ru) 1996-12-10
ZA922777B (en) 1993-10-15
IL101704A0 (en) 1992-12-30
CY1946A (en) 1992-04-27
CS127792A3 (en) 1992-11-18
KR920019365A (ko) 1992-11-19
NO921617L (no) 1992-10-30
FI921876L (fi) 1992-10-30
NO921616L (no) 1992-10-30
DK0511800T3 (da) 1997-04-21
HUT62595A (en) 1993-05-28
NO921617D0 (no) 1992-04-27
IL101704A (en) 1998-02-22
TW315371B (cg-RX-API-DMAC7.html) 1997-09-11
CY1975A (en) 1997-09-05
NO180450B (no) 1997-01-13
NZ242505A (en) 1993-06-25
IE76296B1 (en) 1997-10-08
IL101705A0 (en) 1992-12-30
JPH05117289A (ja) 1993-05-14
JPH05117154A (ja) 1993-05-14
HU9201398D0 (en) 1992-07-28
AU655978B2 (en) 1995-01-19
BR9201541A (pt) 1992-12-01
TW216399B (cg-RX-API-DMAC7.html) 1993-11-21
ATE138924T1 (de) 1996-06-15
HU215917B (hu) 1999-03-29
KR100193742B1 (ko) 1999-06-15
HUT63956A (en) 1993-11-29
ATE144425T1 (de) 1996-11-15
HU9203168D0 (en) 1992-12-28
FI101795B (fi) 1998-08-31
CN1066186A (zh) 1992-11-18
JP3333545B2 (ja) 2002-10-15
FI101795B1 (fi) 1998-08-31
CA2067274A1 (en) 1992-10-30
DE69214710T2 (de) 1997-03-13
EP0511799B1 (en) 1996-06-05
YU44392A (sh) 1994-12-28
FI921877L (fi) 1992-10-30
FI921876A7 (fi) 1992-10-30
JP3135672B2 (ja) 2001-02-19
CZ282218B6 (cs) 1997-06-11
NO180450C (no) 1997-04-23
AU1525592A (en) 1992-11-05
MX9201946A (es) 1992-11-01
IE921345A1 (en) 1992-11-04
IE921346A1 (en) 1992-11-04
CA2067275A1 (en) 1992-10-30
MY109498A (en) 1997-02-28
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
GR3020439T3 (en) 1996-10-31
HU213613B (en) 1997-08-28
EP0511800A1 (en) 1992-11-04
NZ242506A (en) 1993-09-27
NO921616D0 (no) 1992-04-27
NO179504C (no) 1996-10-23
RU2045953C1 (ru) 1995-10-20
IE74885B1 (en) 1997-08-13
HK215096A (en) 1996-12-13
DE69214710D1 (de) 1996-11-28
ES2093779T3 (es) 1997-01-01
AU646734B2 (en) 1994-03-03
CA2067274C (en) 2002-10-15
NO179504B (no) 1996-07-15
CN1030611C (zh) 1996-01-03
GR3021706T3 (en) 1997-02-28
CS127692A3 (en) 1992-11-18
EP0511799A1 (en) 1992-11-04
DK0511799T3 (da) 1996-06-24

Similar Documents

Publication Publication Date Title
EP2785702B1 (en) Crystalline dapagliflozin hydrate
EP1103558B1 (en) Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
KR20010099806A (ko) 아지트로마이신의 에탄올레이트, 이것의 제조 방법 및약학 조성물
EP1189915A1 (en) Process for the production of azithromycin
EP0511799B1 (en) Pharmaceutical compounds
US6627743B1 (en) 6-O-methylerythromycin A crystal form III
EP1246831A4 (en) METHOD FOR PRODUCING AZITHROMYCINE DIHYDRATE
KR100431431B1 (ko) 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
CN115181109A (zh) 吗啡喃衍生物的晶体及其制备方法
CA2417353C (en) Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
KR100375957B1 (ko) D4t 동질이상 i 형의 제조방법
JP2003503506A (ja) ４”−置換−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体の二リン酸塩及びその医薬組成物
US9127018B2 (en) Solid forms of ortataxel
KR20200039750A (ko) 약학적 조성물의 제조 방법
CN111094313B (zh) 盐酸伊达比星一水合物的晶型
EP4610253A1 (en) Crystals of naphthalene derivative
EP4467557A1 (en) Crystal of 4'-substituted nucleoside, preparation method therefor, composition containing same, and use thereof
EP4467558A1 (en) Crystal of 4'-substituted nucleoside, and preparation method therefor, composition thereof and use thereof
RU2130942C1 (ru) Способ получения 3'-азидо-2', 3'-дидезокситимидина
CA2485433C (en) Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
KR100212939B1 (ko) 새로운 결정구조의 시타라빈 옥포스페이트 나트륨염 일수화물
CA2575376A1 (en) Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene-17beta-carboxylic acid and processes for preparationthereof
MXPA04010587A (es) [2r-(2r*, 3s*, 4r*, 5r*, 8r*, 10r*, 11r*, 2s*, 3s*, 14r*)]- 13-[(2 6-d deoxi-3-c- metil- -l- ribo- hexopiranosil) oxi]-2-etil-3], 4, 10- trihidroxi-3, 5, 6, 8, 10, 12, 14-heptametil- 11-[[3, 4, 6-trideoxi- 3-(dimetilamino)- -d-xilo-5 hexopiranosil] o
HK1118294A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

G170 Re-publication after modification of scope of protection [patent]
PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20070108

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20080209

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20080209

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000